# Psychosis TMS Study

> **NCT05857137** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Psychosis

## Interventions

- **DEVICE:** Active TMS
- **DEVICE:** Placebo TMS

## Key facts

- **NCT ID:** NCT05857137
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-04
- **Primary completion:** 2026-04-15
- **Final completion:** 2026-07-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05857137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05857137, "Psychosis TMS Study". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT05857137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*